Prevalence of Amyloidosis in Trauma Patients (NCT06527521) | Clinical Trial Compass
RecruitingNot Applicable
Prevalence of Amyloidosis in Trauma Patients
Spain246 participantsStarted 2024-11-13
Plain-language summary
This study aims to determine the frequency of amyloidosis among patients undergoing trauma surgery.
Who can participate
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Men and women included in the waiting list for scheduled trauma surgery with at least one of the following criteria defined as red flags: Over 65 years old; Possible family history of amyloidosis, Cardiac pathology: aortic stenosis, presence of left ventricular hypertrophy defined as interventricular septal thickness \> 12mm measured by echocardiography, history of previous brady- or tachyarrhythmias including cardiac conduction blocks, history of syncope or presyncope, pro BNP \> 300 in previous blood tests; History of sensory peripheral neuropathy; History of nephropathy without etiological diagnosis; History of liver disease without a clear cause.
* Ability to cooperate in the necessary evaluations.
* Signed informed consent for inclusion in the study, either by the participant or their legal representative.
Exclusion Criteria:
\- Participants previously diagnosed with amyloidosis cannot be included in the study.
What they're measuring
1
Amyloidosis
Timeframe: One month
Trial details
NCT IDNCT06527521
SponsorConsorci Sanitari de l'Alt Penedès i Garraf